AveXis initiates phase III SPRINT trial of AVXS-101 in presymptomatic patients with SMA April 26, 2018
Zealand holds end-of-phase II meeting with FDA on glepaglutide for short bowel syndrome April 26, 2018
Maxinovel Pharmaceuticals presents the discovery of small-molecule PD-1/PD-L1 inhibitors April 26, 2018
Phase III results presented for solriamfetol on excessive sleep in narcolepsy patients April 26, 2018
Phase IIb/III rheumatoid arthritis study of upadacitinib in Japanese patients meets primary endpoint April 26, 2018
Entasis Therapeutics and Zai Lab enter strategic development collaboration for ETX-2514 April 26, 2018
RSS